The 2020 WHO Classification of Tumors of Bone: An Updated Review

被引:235
作者
Choi, Joon Hyuk [1 ]
Ro, Jae Y. [2 ]
机构
[1] Yeungnam Univ, Dept Pathol, Coll Med, 170 Hyeonchung Ro, Daegu 42415, South Korea
[2] Cornell Univ, Houston Methodist Hosp, Weill Med Coll, Dept Pathol & Genom Med, Houston, TX USA
关键词
WHO classification; bone; tumor; sarcoma; genetics; GIANT-CELL TUMOR; POORLY DIFFERENTIATED CHORDOMA; GENETICALLY-DISTINCT-VARIANT; INTERNAL TANDEM DUPLICATION; CIC-REARRANGED SARCOMAS; ROSAI-DORFMAN DISEASE; DEDIFFERENTIATED CHONDROSARCOMA; EPITHELIOID HEMANGIOENDOTHELIOMA; SOFT-TISSUE; FIBROCARTILAGINOUS MESENCHYMOMA;
D O I
10.1097/PAP.0000000000000293
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Bone tumors are a rare and heterogeneous group of neoplasms that occur in the bone. The diversity and considerable morphologic overlap of bone tumors with other mesenchymal and nonmesenchymal bone lesions can complicate diagnosis. Accurate histologic diagnosis is crucial for appropriate management and prognostication. Since the publication of the fourth edition of the World Health Organization (WHO) classification of tumors of soft tissue and bone in 2013, significant advances have been made in our understanding of bone tumor molecular biology, classification, prognostication, and treatment. Detection of tumor-specific molecular alterations can facilitate the accurate diagnosis of histologically challenging cases. The fifth edition of the 2020 WHO classification of tumors of soft tissue and bone tumors provides an updated classification scheme and essential diagnostic criteria for bone tumors. Herein, we summarize these updates, focusing on major changes in each category of bone tumor, the newly described tumor entities and subtypes of existing tumor types, and newly described molecular and genetic data.
引用
收藏
页码:119 / 138
页数:20
相关论文
共 229 条
[41]  
2-N
[42]  
Bovee JVMG., 2020, The WHO classification of tumours editorial board. WHO classification of tumours, V5, P375
[43]  
Bovee JVMG, 2020, WHO CLASSIFICATION T, P428
[44]  
Bovee JVMG, 2020, WHO CLASSIFICATION T, P373
[45]  
BRADY MS, 1992, ARCH SURG-CHICAGO, V127, P1379
[46]   Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma [J].
Bridge, Julia A. ;
Sumegi, Janos ;
Druta, Mihaela ;
Bui, Marilyn M. ;
Henderson-Jackson, Evita ;
Linos, Konstantinos ;
Baker, Michael ;
Walko, Christine M. ;
Millis, Sherri ;
Brohl, Andrew S. .
MODERN PATHOLOGY, 2019, 32 (11) :1593-1604
[47]   Benign and malignant cartilage tumors of bone and joint: Their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology .1. The intramedullary cartilage tumors [J].
Brien, EW ;
Mirra, JM ;
Kerr, R .
SKELETAL RADIOLOGY, 1997, 26 (06) :325-353
[48]   How safe is curettage of low-grade cartilaginous neoplasms diagnosed by imaging with or without pre-operative needle biopsy? [J].
Brown, M. T. ;
Gikas, P. D. ;
Bhamra, J. S. ;
Skinner, J. A. ;
Aston, W. J. S. ;
Pollock, R. C. ;
Saifuddin, A. ;
Briggs, T. W. R. .
BONE & JOINT JOURNAL, 2014, 96B (08) :1098-1105
[49]   FIBROCARTILAGENOUS MESENCHYMOMA OF BONE [J].
BULYCHOVA, IV ;
UNNI, KK ;
BERTONI, F ;
BEABOUT, JW .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1993, 17 (08) :830-836
[50]   Conventional Primary Central Chondrosarcoma of the Pelvis Prognostic Factors and Outcome of Surgical Treatment in 162 Patients [J].
Bus, Michael P. A. ;
Campanacci, Domenico A. ;
Albergo, Jose I. ;
Leithner, Andreas ;
van de Sande, Michiel A. J. ;
Gaston, Czar Louie ;
Caff, Giuseppe ;
Mettelsiefen, Jan ;
Capanna, Rodolfo ;
Tunn, Per-Ulf ;
Jeys, Lee M. ;
Dijkstra, P. D. Sander .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2018, 100 (04) :316-325